Combination Therapy for Chronic Hepatitis B: Current Indications

Hepatitis B infection remains a major public health problem globally and in the United States, with significant use of healthcare resources. Several therapeutic agents active against viral and host targets are currently available for its treatment. The success of combination therapy in HIV infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Navin, Han, Steven-Huy
Formato: Texto
Lenguaje:English
Publicado: Current Science Inc. 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085106/
https://www.ncbi.nlm.nih.gov/pubmed/21654909
http://dx.doi.org/10.1007/s11901-011-0095-1
_version_ 1782202593418674176
author Paul, Navin
Han, Steven-Huy
author_facet Paul, Navin
Han, Steven-Huy
author_sort Paul, Navin
collection PubMed
description Hepatitis B infection remains a major public health problem globally and in the United States, with significant use of healthcare resources. Several therapeutic agents active against viral and host targets are currently available for its treatment. The success of combination therapy in HIV infection, which has similarities to hepatitis B in both therapeutic targets and treatment options, stimulated studies on the efficacy and safety of various combinations of available drugs in the treatment of hepatitis B infection. In this review, we analyze the current role of combination therapy in chronic hepatitis B infection.
format Text
id pubmed-3085106
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Current Science Inc.
record_format MEDLINE/PubMed
spelling pubmed-30851062011-06-06 Combination Therapy for Chronic Hepatitis B: Current Indications Paul, Navin Han, Steven-Huy Curr Hepat Rep Article Hepatitis B infection remains a major public health problem globally and in the United States, with significant use of healthcare resources. Several therapeutic agents active against viral and host targets are currently available for its treatment. The success of combination therapy in HIV infection, which has similarities to hepatitis B in both therapeutic targets and treatment options, stimulated studies on the efficacy and safety of various combinations of available drugs in the treatment of hepatitis B infection. In this review, we analyze the current role of combination therapy in chronic hepatitis B infection. Current Science Inc. 2011-02-19 2011 /pmc/articles/PMC3085106/ /pubmed/21654909 http://dx.doi.org/10.1007/s11901-011-0095-1 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Paul, Navin
Han, Steven-Huy
Combination Therapy for Chronic Hepatitis B: Current Indications
title Combination Therapy for Chronic Hepatitis B: Current Indications
title_full Combination Therapy for Chronic Hepatitis B: Current Indications
title_fullStr Combination Therapy for Chronic Hepatitis B: Current Indications
title_full_unstemmed Combination Therapy for Chronic Hepatitis B: Current Indications
title_short Combination Therapy for Chronic Hepatitis B: Current Indications
title_sort combination therapy for chronic hepatitis b: current indications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085106/
https://www.ncbi.nlm.nih.gov/pubmed/21654909
http://dx.doi.org/10.1007/s11901-011-0095-1
work_keys_str_mv AT paulnavin combinationtherapyforchronichepatitisbcurrentindications
AT hanstevenhuy combinationtherapyforchronichepatitisbcurrentindications

Ejemplares similares